The E3 ubiquitin ligase Itch regulates death receptor and cholesterol trafficking to affect TRAIL-mediated apoptosis

James Holloway1, Aidan Seeley1, Neville Cobbe1

  • 1Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, 97 Lisburn Road, BT9 7AE, Belfast, UK.

Cell Death & Disease
|January 12, 2024
PubMed

Insights

The E3 ubiquitin ligase Itch regulates mitochondrial cholesterol levels, impacting apoptosis and chemotherapy resistance in oesophageal cancer. Its absence promotes cancer cell survival and resistance to TRAIL, Bcl-2 inhibitors, and cisplatin.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • TRAIL (TNF-related apoptosis-inducing ligand) triggers apoptosis, a process often dysregulated in cancer.
  • Ubiquitination is crucial for regulating TRAIL-mediated apoptosis.
  • Cancer cells develop resistance to apoptosis and chemotherapy.

Purpose of the Study:

  • To investigate the role of the E3 ubiquitin ligase Itch in TRAIL-mediated apoptosis in oesophageal cancer.
  • To elucidate the mechanisms linking Itch, mitochondrial cholesterol, and cancer cell resistance.

Main Methods:

  • Itch expression knockdown in oesophageal cancer cells.
  • Analysis of apoptosis signaling pathways (caspase-8, Bid, Bax).
  • Assessment of mitochondrial morphology and cholesterol content.
  • Investigation of protein-protein interactions and STARD1 stability.

Main Results:

  • Itch knockdown confers resistance to TRAIL, cisplatin, and Bcl-2 inhibitors.
  • Itch deficiency leads to TRAIL-R2 mis-localization and altered mitochondrial morphology.
  • Increased mitochondrial cholesterol and STARD1 stability were observed in Itch-knockdown cells.
  • A novel Itch-VDAC2-STARD1 complex was identified, regulating mitochondrial cholesterol import.

Conclusions:

  • Itch plays a critical role in regulating both extrinsic and intrinsic apoptosis pathways.
  • Itch influences mitochondrial cholesterol levels by controlling STARD1 stability.
  • Dysregulation of Itch contributes to TRAIL, Bcl-2 inhibitor, and cisplatin resistance in cancer.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K